A growing number of women are reportedly bypassing traditional healthcare channels to obtain testosterone, according to reports from menopause specialists. The trend is driven by patients who face significant barriers or delays when attempting to secure legitimate prescriptions for hormone therapy to manage menopause symptoms.

Medical professionals are raising alarms regarding the safety of this practice. Specialists have observed patients who have self-administered testosterone at dosages resulting in blood levels up to 12 times higher than what is considered medically safe. The lack of clinical oversight in these online transactions creates a risk of adverse health effects, as patients may be unaware of the appropriate therapeutic range or the potential side effects of excessive hormone intake.

While the BBC report highlights the perspective of clinicians concerned about patient safety, it does not detail the specific regulatory hurdles or systemic issues that make obtaining a prescription difficult for these women. The report focuses on the clinical consequences of unregulated use rather than the patient experience of navigating the healthcare system.